NCT06549738View on ClinicalTrials.gov

Effects of Intermittent Pneumatic Compression Therapy on Tissue Volume, Pain, and Quality of Life in Lipedema

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 21, 2023

Primary Completion Date

November 16, 2023

Study Completion Date

November 16, 2023

Conditions

Lipedema

Interventions

DEVICE

Intermittent pneumatic compression therapy

Lympha Press Optimal Plus is an advanced intermittent pneumatic compression therapy device. It is FDA cleared (K170658) for the indication of lipedema as well as for other indications for use.

Trial Locations (1)

27713

Carolina Vein Center, Durham

All Listed Sponsors

collaborator

Carolina Vein Center

UNKNOWN

lead

Lympha Press

OTHER